6 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of Halofuginone (CAS-55837-20-2), imported in bulk form, from France
Issued March 30, 2005 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardL8 L83425 (March 30, 2005)
Tariff classification
HTS codes: 2933.59.3600
Headings: 2933
Product description
The subject product, Halofuginone, is indicated for use as a coccidiostat in young chickens and turkeys. Halofuginone also received orphan drug designation from the FDA, in 2001, for the treatment of scleroderma. At the present time, the effectiveness of topically applied Halofuginone hydrobromide in treating patients who have HIV-related Kaposi’s sarcoma is being investigated in an FDA-regulated Phase II clinical trial.
CBP rationale
The applicable subheading for Halofuginone, imported in bulk form, will be 2933.59.3600, Harmonized Tariff Schedule of the United States (HTS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: Other: Drugs: Aromatic or modified aromatic: Anti-infective agents: Other.
Full text
NY L83425 March 30, 2005 CLA-2-29:RR:NC:2:238 L83425 CATEGORY: Classification TARIFF NO.: 2933.59.3600 Mr. Joseph J. Chivini Austin Chemical Company, Inc. 1565 Barclay Boulevard Buffalo Grove, IL 60089 RE: The tariff classification of Halofuginone (CAS-55837-20-2), imported in bulk form, from France Dear Mr. Chivini: In your letter dated March 7, 2005, you requested a tariff classification ruling. The subject product, Halofuginone, is indicated for use as a coccidiostat in young chickens and turkeys. Halofuginone also received orphan drug designation from the FDA, in 2001, for the treatment of scleroderma. At the present time, the effectiveness of topically applied Halofuginone hydrobromide in treating patients who have HIV-related Kaposi’s sarcoma is being investigated in an FDA-regulated Phase II clinical trial. The applicable subheading for Halofuginone, imported in bulk form, will be 2933.59.3600, Harmonized Tariff Schedule of the United States (HTS), which provides for “Heterocyclic compounds with nitrogen hetero-atom(s) only: Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: Other: Drugs: Aromatic or modified aromatic: Anti-infective agents: Other.” Pursuant to General Note 13, HTS, the rate of duty will be free. This merchandise may be subject to the requirements of the Federal Food, Drug, and Cosmetic Act, which is administered by the U.S. Food and Drug Administration. You may contact them at 5600 Fishers Lane, Rockville, Maryland 20857, telephone number 1-888-443-6332. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Letermovir (CAS No. 917389-32-3) in bulk form, from India
The tariff classification of Rilpivirine (CAS No. 500287-72-9) in bulk form, from Canada
The tariff classification of Various Chemical Compounds from China
The tariff classification of Praziquantel (CAS-55268-74-1), imported in bulk form, from Italy
The tariff classification of Voriconazole (CAS-137234-62-9) in bulk form, from China
The tariff classification of Danofloxacin Mesylate (CAS-119478-55-6) in bulk form, from China
The tariff classification of 1-Amino-2-(Propylsulfonyl) Benzene (CAS 76697-58-0) from the Czech Republic; 2-Aminophenyl Isopropylsulfone (CAS 76697-50-2) from the Czech Republic; and Gatifloxacin (CAS 180200-66-2) from Mexico.
The tariff classification of Methy-3-Amino-4-Methylthiophene-2-Carboxylate (CAS 85006-31-1) and Diethyl Phenylsulfonylfluoromethylphosphate (114968-97-7) from France; and Ciprofloxacin (CAS 85721-33-1), imported in bulk form, from Spain.
The tariff classification of Gatifloxacin (CAS-180200-66-2), imported in bulk form, from Japan
The tariff classification of Ciprofloxacin (CAS-85721-33-1), imported in bulk form, from China
Follow L83425
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.